Edwards Lifesciences Corporation (EW)
NYSE: EW ยท Real-Time Price ยท USD
101.85
-2.03 (-1.95%)
At close: Nov 20, 2026, 4:00 PM EST
101.94
+0.09 (0.09%)
After-hours: Nov 20, 2026, 7:59 PM EST
Edwards Lifesciences Revenue
Edwards Lifesciences had revenue of $1.72B in the quarter ending September 30, 2026, with 10.46% growth. This brings the company's total for the last twelve months to $6.67B, up 13.44% year-over-year. In the year 2025, Edwards Lifesciences had annual revenue of $6.07B with 11.55% growth. That makes Edwards Lifesciences the 2,096th largest company in the world by revenue and 623rd in the United States.
Revenue (ttm)
$6.67B
Revenue Growth
+13.44%
P/S Ratio
8.77
Revenue / Employee
$417,169
Employees
16,000
Market Cap
58.56B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Edwards Lifesciences breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.07B | 628.10M | 11.55% |
| Dec 31, 2024 | 5.44B | 429.50M | 8.57% |
| Dec 31, 2023 | 5.01B | 546.00M | 12.23% |
| Dec 31, 2022 | 4.46B | -768.50M | -14.69% |
| Dec 31, 2021 | 5.23B | 846.20M | 19.29% |
| Dec 31, 2020 | 4.39B | 38.30M | 0.88% |
| Dec 31, 2019 | 4.35B | 625.20M | 16.79% |
| Dec 31, 2018 | 3.72B | 287.50M | 8.37% |
| Dec 31, 2017 | 3.44B | 471.60M | 15.91% |
| Dec 31, 2016 | 2.96B | 470.00M | 18.85% |
| Dec 31, 2015 | 2.49B | 170.80M | 7.35% |
| Dec 31, 2014 | 2.32B | 277.40M | 13.56% |
| Dec 31, 2013 | 2.05B | 145.90M | 7.68% |
| Dec 31, 2012 | 1.90B | 221.00M | 13.17% |
| Dec 31, 2011 | 1.68B | 231.60M | 16.01% |
| Dec 31, 2010 | 1.45B | 125.60M | 9.51% |
| Dec 31, 2009 | 1.32B | 83.70M | 6.76% |
| Dec 31, 2008 | 1.24B | 146.60M | 13.44% |
| Dec 31, 2007 | 1.09B | 54.10M | 5.22% |
| Dec 31, 2006 | 1.04B | 39.10M | 3.92% |
| Dec 31, 2005 | 997.90M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories | 48.23B |
| Medtronic | 37.54B |
| Stryker | 26.30B |
| GE HealthCare Technologies | 21.64B |
| Boston Scientific | 21.07B |
| Koninklijke Philips | 20.16B |
| Zimmer Biomet Holdings | 8.57B |
| STERIS | 6.17B |
EW News
- 1 day ago - Edwards Lifesciences growth expected to continue, says RBC Capital - TheFly
- 2 days ago - Edwards Lifesciences price target raised to $116 from $112 at Leerink - TheFly
- 3 days ago - Worried investors are paying up for these stocks โ some with up to 49% upside, analysts say - Market Watch
- 5 days ago - Edwards Lifesciences price target raised to $121 from $113 at Wells Fargo - TheFly
- 7 days ago - Edwards Lifesciences management to meet virtually with Oppenheimer - TheFly
- 7 days ago - Edwards Lifesciences management to meet virtually with Oppenheimer - TheFly
- 16 days ago - Edwards Lifesciences price target raised to $115 from $100 at RBC Capital - TheFly
- 16 days ago - Edwards Lifesciences price target raised to $120 from $105 at Mizuho - TheFly